1
|
Velmurugan KR, Varghese RT, Fonville NC, Garner HR. High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification. Oncogene 2017; 36:6383-6390. [PMID: 28759038 PMCID: PMC5701090 DOI: 10.1038/onc.2017.256] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Revised: 06/01/2017] [Accepted: 06/13/2017] [Indexed: 12/23/2022]
Abstract
There remains a large discrepancy between the known genetic contributions to cancer and that which can be explained by genomic variants, both inherited and somatic. Recently, understudied repetitive DNA regions called microsatellites have been identified as genetic risk markers for a number of diseases including various cancers (breast, ovarian and brain). In this study, we demonstrate an integrated process for identifying and further evaluating microsatellite-based risk markers for lung cancer using data from the cancer genome atlas and the 1000 genomes project. Comparing whole-exome germline sequencing data from 488 TCGA lung cancer samples to germline exome data from 390 control samples from the 1000 genomes project, we identified 119 potentially informative microsatellite loci. These loci were found to be able to distinguish between cancer and control samples with sensitivity and specificity ratios over 0.8. Then these loci, supplemented with additional loci from other cancers and controls, were evaluated using a target enrichment kit and sample-multiplexed nextgen sequencing. Thirteen of the 119 risk markers were found to be informative in a well powered study (>0.99 for a 0.95 confidence interval) using high-depth (579x±315) nextgen sequencing of 30 lung cancer and 89 control samples, resulting in sensitivity and specificity ratios of 0.90 and 0.94, respectively. When 8 loci harvested from the bioinformatic analysis of other cancers are added to the classifier, then the sensitivity and specificity rise to 0.93 and 0.97, respectively. Analysis of the genes harboring these loci revealed two genes (ARID1B and REL) and two significantly enriched pathways (chromatin organization and cellular stress response) suggesting that the process of lung carcinogenesis is linked to chromatin remodeling, inflammation, and tumor microenvironment restructuring. We illustrate that high-depth sequencing enables a high-precision microsatellite-based risk classifier analysis approach. This microsatellite-based platform confirms the potential to create clinically actionable diagnostics for lung cancer.
Collapse
Affiliation(s)
- K R Velmurugan
- Department of Biological Sciences, Center for Bioinformatics and Genetics and the Primary Care Research Network, Edward Via College of Osteopathic Medicine, Blacksburg, VA, USA.,Department of Biological Sciences, Gibbs Cancer Center and Research Institute, Spartanburg, SC, USA
| | - R T Varghese
- Department of Biological Sciences, Center for Bioinformatics and Genetics and the Primary Care Research Network, Edward Via College of Osteopathic Medicine, Blacksburg, VA, USA.,Department of Biological Sciences, Gibbs Cancer Center and Research Institute, Spartanburg, SC, USA
| | - N C Fonville
- Department of Biological Sciences, Riverside Law, LLP Glenhardie Corporate Center, Wayne, PA, USA
| | - H R Garner
- Department of Biological Sciences, Center for Bioinformatics and Genetics and the Primary Care Research Network, Edward Via College of Osteopathic Medicine, Blacksburg, VA, USA.,Department of Biological Sciences, Gibbs Cancer Center and Research Institute, Spartanburg, SC, USA
| |
Collapse
|
2
|
Immune DNA signature of T-cell infiltration in breast tumor exomes. Sci Rep 2016; 6:30064. [PMID: 27452728 PMCID: PMC4958917 DOI: 10.1038/srep30064] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Accepted: 06/27/2016] [Indexed: 12/11/2022] Open
Abstract
Tumor infiltrating lymphocytes (TILs) have been associated with favorable prognosis in multiple tumor types. The Cancer Genome Atlas (TCGA) represents the largest collection of cancer molecular data, but lacks detailed information about the immune environment. Here, we show that exome reads mapping to the complementarity-determining-region 3 (CDR3) of mature T-cell receptor beta (TCRB) can be used as an immune DNA (iDNA) signature. Specifically, we propose a method to identify CDR3 reads in a breast tumor exome and validate it using deep TCRB sequencing. In 1,078 TCGA breast cancer exomes, the fraction of CDR3 reads was associated with TILs fraction, tumor purity, adaptive immunity gene expression signatures and improved survival in Her2+ patients. Only 2/839 TCRB clonotypes were shared between patients and none associated with a specific HLA allele or somatic driver mutations. The iDNA biomarker enriches the comprehensive dataset collected through TCGA, revealing associations with other molecular features and clinical outcomes.
Collapse
|